NASDAQ:BIB - ProShares Ultra Nasdaq Biotechnology ETF Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$59.60 -0.47 (-0.78 %)
(As of 06/22/2018 04:00 PM ET)
Previous Close$60.07
Today's Range$59.23 - $60.52
52-Week Range$48.12 - $69.62
Volume67,806 shs
Average Volume200,348 shs
Market Capitalization$435.56 million
P/E RatioN/A
Dividend Yield0.00%
Beta2.75
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

Receive BIB News and Ratings via Email

Sign-up to receive the latest news and ratings for BIB and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer ProShares
Fund NameProShares Ultra Nasdaq Biotechnology
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:BIB
Inception Date4/7/2010
Fund ManagerMichael Neches, Devin Sullivan
Phone+1-240-4976400

Fund Focus

Asset ClassEquity
BenchmarkNASDAQ Biotechnology TR USD
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$350.33 million
Average Daily Volume$202,882.00
Discount/Premium-2.73%

ETF Expenses

Management Fee0.75%
Other Expenses0.29%
Total Expenses1.04%
Fee Waiver-0.09%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerVirtu Financial

Geographic Exposure of ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB)
Currency Exposure of ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB)
Sector Exposure of ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB)
Industry Exposure of ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB)

ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) Frequently Asked Questions

What is ProShares Ultra Nasdaq Biotechnology ETF's stock symbol?

ProShares Ultra Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "BIB."

Has ProShares Ultra Nasdaq Biotechnology ETF been receiving favorable news coverage?

Headlines about BIB stock have been trending somewhat negative on Saturday, Accern Sentiment Analysis reports. The research firm identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. ProShares Ultra Nasdaq Biotechnology ETF earned a media sentiment score of -0.02 on Accern's scale. They also gave media headlines about the exchange traded fund an impact score of 46.70 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Who are ProShares Ultra Nasdaq Biotechnology ETF's major shareholders?

ProShares Ultra Nasdaq Biotechnology ETF's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BKS Advisors LLC (0.32%). View Institutional Ownership Trends for ProShares Ultra Nasdaq Biotechnology ETF.

Which institutional investors are selling ProShares Ultra Nasdaq Biotechnology ETF stock?

BIB stock was sold by a variety of institutional investors in the last quarter, including BKS Advisors LLC. View Insider Buying and Selling for ProShares Ultra Nasdaq Biotechnology ETF.

How do I buy shares of ProShares Ultra Nasdaq Biotechnology ETF?

Shares of BIB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ProShares Ultra Nasdaq Biotechnology ETF's stock price today?

One share of BIB stock can currently be purchased for approximately $59.60.

How big of a company is ProShares Ultra Nasdaq Biotechnology ETF?

ProShares Ultra Nasdaq Biotechnology ETF has a market capitalization of $435.56 million.

How can I contact ProShares Ultra Nasdaq Biotechnology ETF?

ProShares Ultra Nasdaq Biotechnology ETF's mailing address is SUITE 1000, 7501 WISCONSIN AVENUE, BETHESDA, MD 20814, United States. The exchange traded fund can be reached via phone at +1-240-4976400.


MarketBeat Community Rating for ProShares Ultra Nasdaq Biotechnology ETF (BIB)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  33 (Vote Outperform)
Underperform Votes:  43 (Vote Underperform)
Total Votes:  76
MarketBeat's community ratings are surveys of what our community members think about ProShares Ultra Nasdaq Biotechnology ETF and other stocks. Vote "Outperform" if you believe BIB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BIB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.